Click on the article title to read more.

The appropriate duration of anticoagulation for venous thromboembolism (VTE) in patients who have a transient provoking factor (e.g., surgery, trauma, or immobility) and concomitant enduring risk f...

This clinical trial compares the efficacy and safety of prothrombin complex concentrate with frozen plasma in patients requiring coagulation factor replacement for bleeding during cardiac surgery.

This cross-sectional study evaluates the risk associated with protein S deficiency across multiple arterial thrombosis phenotypes in population-level cohorts.

In patients with active cancer and venous thromboembolism, whether extended treatment with a reduced dose of an oral anticoagulant is effective in preventing recurrent thromboembolic events and dec...

A 23-year-old presented to the emergency room with a headache and a fever of 101.5 degrees Fahrenheit. Physical examination revealed a fatigued patient wit

In this editorial, we use the term “women” to highlight the experiences of and care gaps for women with nonanemic iron deficiency (NAID) and iron deficiency anemia (IDA) and the term “females” in refe...

Background Acquired haemophilia A (AHA) is an acquired bleeding disorder resulting from autoantibodies against Factor VIII (FVIII). Previous studies have reported differences in FVIII inhibitor kine...

PURPOSEMost clinical trials are conducted exclusively in high-income countries (HICs), with only a small fraction involving centers from low-middle income countries (LMICs). However, studies evaluatin...

Key PointsDonor platelets can be directly genetically modified in plasma and platelet additive solution using mRNA-lipid nanoparticles.mRNA-LNP transfectio